Ceftriaxone Pfizer

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Ceftriaxone sodium 2386mg equivalent to ceftriaxone 2000 mg

Available from:

Pfizer New Zealand Limited

INN (International Name):

Ceftriaxone sodium 2386 mg (equivalent to ceftriaxone 2000 mg)

Dosage:

2 g

Pharmaceutical form:

Powder for injection

Composition:

Active: Ceftriaxone sodium 2386mg equivalent to ceftriaxone 2000 mg

Units in package:

Vial, glass, single dose, Type I, clear, with rubber stopper seal and Al seal and PP lemon yellow colour disc; 1 vial, 2 g

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Aurobindo Pharma Limited

Therapeutic indications:

Infections caused by pathogens sensitive to ceftriaxone, e.g.: · sepsis; · meningitis; · abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); · infections of the bones, joints, soft tissue, skin and of wounds; · infections in patients with impaired defence mechanisms; · renal and urinary tract infections; · respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; · genital infections, including gonorrhoea. · Perioperative prophylaxis of infections.

Product summary:

Package - Contents - Shelf Life: Vial, glass, single dose, Type I, clear, with rubber stopper seal and Al seal and PP lemon yellow colour disc; 1 vial - 2 g - 24 months from date of manufacture stored at or below 30°C protect from light 6 hours reconstituted stored at or below 25°C 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Authorization date:

2010-10-12